Claritin Syrup (loratadine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved October 1996

Specific Treatments:

seasonal allergies in children

Find Related Trials for The Following Conditions

General Information

Claritin Syrup has been approved as a non-drowsy antihistamine syrup for children as young as six years of age. In addition, the indication for Claritin tablets was expanded to include children age six years and up.

Available only by prescription in a once-daily formula, Claritin Syrup is indicated for the treatment of allergy symptoms, including itchy, watery eyes; runny nose; itchy palate; sneezing; and idiopathic chronic urticaria (hives).

Claritin Syrup, in an alcohol-free and dye-free fruit flavored formula, is administered orally at a dose of two teaspoons once-per-day for children as young as six years of age.

Clinical Results

In controlled clinical trials using the recommended dose, the incidence of the most commonly reported adverse events was comparable to placebo.